Multiple Assemblies exist for SMTL entry 5xsu
novel orally efficacious inhibitors complexed with PARP1; X-RAY DIFFRACTION 2.40 Å

	SMTL ID 5xsu.1 Ligands SULFATE ION; 6-fluoranyl-2-(4,5,6,7-tetrahydrofuro[2,3-c]pyridin-2-yl)-1~{H}-benzimidazole-4-carboxamide Polypeptides Poly [ADP-ribose] polymerase 1 Oligo-state monomer
	SMTL ID 5xsu.2 Ligands SULFATE ION; 6-fluoranyl-2-(4,5,6,7-tetrahydrofuro[2,3-c]pyridin-2-yl)-1~{H}-benzimidazole-4-carboxamide Polypeptides Poly [ADP-ribose] polymerase 1 Oligo-state monomer
	SMTL ID 5xsu.3 Ligands SULFATE ION; 6-fluoranyl-2-(4,5,6,7-tetrahydrofuro[2,3-c]pyridin-2-yl)-1~{H}-benzimidazole-4-carboxamide Polypeptides Poly [ADP-ribose] polymerase 1 Oligo-state monomer
	SMTL ID 5xsu.4 Ligands SULFATE ION; 6-fluoranyl-2-(4,5,6,7-tetrahydrofuro[2,3-c]pyridin-2-yl)-1~{H}-benzimidazole-4-carboxamide Polypeptides Poly [ADP-ribose] polymerase 1 Oligo-state monomer